Phillip J. Wilder

1.2k total citations
29 papers, 1.0k citations indexed

About

Phillip J. Wilder is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Phillip J. Wilder has authored 29 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 11 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Phillip J. Wilder's work include Pluripotent Stem Cells Research (7 papers), TGF-β signaling in diseases (6 papers) and Fibroblast Growth Factor Research (4 papers). Phillip J. Wilder is often cited by papers focused on Pluripotent Stem Cells Research (7 papers), TGF-β signaling in diseases (6 papers) and Fibroblast Growth Factor Research (4 papers). Phillip J. Wilder collaborates with scholars based in United States, Japan and Morocco. Phillip J. Wilder's co-authors include Angie Rizzino, Michelle Desler, Rodney D. McComb, Jesse L. Cox, Arnaud Chatonnet, Judith A. Stribley, Weihua Xie, Palmer Taylor, Steven H. Hinrichs and Oksana Lockridge and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Phillip J. Wilder

29 papers receiving 996 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Phillip J. Wilder United States 17 747 210 161 116 97 29 1.0k
Mirta Grifman Israel 14 531 0.7× 214 1.0× 105 0.7× 33 0.3× 95 1.0× 19 810
Cédric Malicet France 17 697 0.9× 172 0.8× 217 1.3× 164 1.4× 9 0.1× 23 1.1k
Angela McCahill United Kingdom 12 839 1.1× 200 1.0× 87 0.5× 87 0.8× 11 0.1× 17 1.0k
Yvonne M. Yannoni United States 9 667 0.9× 147 0.7× 91 0.6× 74 0.6× 12 0.1× 10 916
Juan Luo China 7 970 1.3× 49 0.2× 186 1.2× 224 1.9× 22 0.2× 10 1.4k
Huira Chong United States 9 748 1.0× 30 0.1× 167 1.0× 55 0.5× 50 0.5× 9 1.1k
Angélique Wright United States 4 525 0.7× 40 0.2× 79 0.5× 65 0.6× 33 0.3× 6 777
Sangeeta Dhawan United States 22 970 1.3× 98 0.5× 86 0.5× 84 0.7× 30 0.3× 59 1.9k
Joana M. Xavier Portugal 16 537 0.7× 38 0.2× 112 0.7× 191 1.6× 16 0.2× 27 980
Shinichi Inohara Japan 10 858 1.1× 55 0.3× 92 0.6× 40 0.3× 44 0.5× 24 1.1k

Countries citing papers authored by Phillip J. Wilder

Since Specialization
Citations

This map shows the geographic impact of Phillip J. Wilder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip J. Wilder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip J. Wilder more than expected).

Fields of papers citing papers by Phillip J. Wilder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip J. Wilder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip J. Wilder. The network helps show where Phillip J. Wilder may publish in the future.

Co-authorship network of co-authors of Phillip J. Wilder

This figure shows the co-authorship network connecting the top 25 collaborators of Phillip J. Wilder. A scholar is included among the top collaborators of Phillip J. Wilder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip J. Wilder. Phillip J. Wilder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akbar, Anum, Phillip J. Wilder, Nagendra K. Chaturvedi, et al.. (2023). STAT3 Inhibition Attenuates MYC Expression by Modulating Co-Activator Recruitment and Suppresses Medulloblastoma Tumor Growth by Augmenting Cisplatin Efficacy In Vivo. Cancers. 15(8). 2239–2239. 5 indexed citations
2.
Wilder, Phillip J., Jing Wang, Qi Liu, et al.. (2022). Elevating SOX2 Downregulates MYC through a SOX2:MYC Signaling Axis and Induces a Slowly Cycling Proliferative State in Human Tumor Cells. Cancers. 14(8). 1946–1946. 4 indexed citations
3.
Wuebben, Erin L., Phillip J. Wilder, Jesse L. Cox, et al.. (2020). Tumor quiescence: elevating SOX2 in diverse tumor cell types downregulates a broad spectrum of the cell cycle machinery and inhibits tumor growth. BMC Cancer. 20(1). 941–941. 13 indexed citations
4.
Cox, Jesse L., Phillip J. Wilder, Erin L. Wuebben, et al.. (2014). Context-dependent function of the deubiquitinating enzyme USP9X in pancreatic ductal adenocarcinoma. Cancer Biology & Therapy. 15(8). 1042–1052. 28 indexed citations
5.
Cox, Jesse L., Phillip J. Wilder, Michelle Desler, & Angie Rizzino. (2012). Elevating SOX2 Levels Deleteriously Affects the Growth of Medulloblastoma and Glioblastoma Cells. PLoS ONE. 7(8). e44087–e44087. 49 indexed citations
6.
Babayeva, Nigar D., et al.. (2010). Crystal Structure of Mouse Elf3 C-terminal DNA-binding Domain in Complex with Type II TGF-β Receptor Promoter DNA. Journal of Molecular Biology. 397(1). 278–289. 21 indexed citations
7.
Babayeva, Nigar D., Phillip J. Wilder, Masaaki Shiina, et al.. (2010). Structural basis of Ets1 cooperative binding to palindromic sequences on stromelysin-1 promoter DNA.. PubMed. 9(15). 3054–62. 27 indexed citations
8.
Boer, Bauke de, Janel L. Kopp, Sunil K. Mallanna, et al.. (2007). Elevating the levels of Sox2 in embryonal carcinoma cells and embryonic stem cells inhibits the expression of Sox2:Oct-3/4 target genes. Nucleic Acids Research. 35(6). 1773–1786. 95 indexed citations
9.
10.
Kopp, Janel L., Phillip J. Wilder, Michelle Desler, et al.. (2004). Unique and Selective Effects of Five Ets Family Members, Elf3, Ets1, Ets2, PEA3, and PU.1, on the Promoter of the Type II Transforming Growth Factor-β Receptor Gene. Journal of Biological Chemistry. 279(19). 19407–19420. 37 indexed citations
11.
Ge, Baosheng, Olga Li, Phillip J. Wilder, Angie Rizzino, & Timothy W. McKeithan. (2003). NF-κB Regulates BCL3 Transcription in T Lymphocytes Through an Intronic Enhancer. The Journal of Immunology. 171(8). 4210–4218. 37 indexed citations
12.
Kim, Jaehwan, Phillip J. Wilder, Jingwen Hou, Tamara K. Nowling, & Angie Rizzino. (2002). Activation of the Murine Type II Transforming Growth Factor-β Receptor Gene. Journal of Biological Chemistry. 277(20). 17520–17530. 29 indexed citations
13.
Wilder, Phillip J., Michelle Desler, Tamara K. Nowling, & Angie Rizzino. (2001). Isolation and characterization of the murine transforming growth factor-β2 promoter. Gene. 270(1-2). 201–209. 5 indexed citations
14.
Xie, Weihua, Phillip J. Wilder, Judith A. Stribley, et al.. (1999). Knockout of one acetylcholinesterase allele in the mouse. Chemico-Biological Interactions. 119-120. 289–299. 27 indexed citations
15.
Wilder, Phillip J., David L. Kelly, Cynthia L. Peterson, et al.. (1997). Inactivation of the FGF-4 Gene in Embryonic Stem Cells Alters the Growth and/or the Survival of Their Early Differentiated Progeny. Developmental Biology. 192(2). 614–629. 103 indexed citations
16.
Wilder, Phillip J., et al.. (1997). DNA Sequence and Nucleosome Placement on the Murine Fibroblast Growth Factor-4 Gene. DNA sequence. 7(2). 117–121. 2 indexed citations
17.
Wilder, Phillip J. & Angie Rizzino. (1993). Mouse genetics in the 21st century: using gene targeting to create a cornucopia of mouse mutants possessing precise genetic modifications. Cytotechnology. 11(2). 79–99. 9 indexed citations
18.
Wilder, Phillip J., et al.. (1993). Fibroblast growth factor complexed to the cytotoxin saporin is growth inhibitory but not cytotoxic for embryonal carcinoma cells. Cytotechnology. 13(2). 69–78. 6 indexed citations
19.
Rosfjord, Edward, et al.. (1992). Transcriptional regulation of the murine k-FGF gene in embryonic cell lines. Developmental Biology. 154(1). 45–54. 66 indexed citations
20.
Wilder, Phillip J. & Angie Rizzino. (1991). Effects of transforming growth factor beta on the anchorage-independent growth of murine epithelial JB6 cells.. PubMed. 51(21). 5898–902. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mirta Grifman Breakdown of academic impact, for papers by Cédric Malicet Breakdown of academic impact, for papers by Angela McCahill Breakdown of academic impact, for papers by Yvonne M. Yannoni Breakdown of academic impact, for papers by Juan Luo Breakdown of academic impact, for papers by Huira Chong Breakdown of academic impact, for papers by Angélique Wright Breakdown of academic impact, for papers by Sangeeta Dhawan Breakdown of academic impact, for papers by Joana M. Xavier Breakdown of academic impact, for papers by Shinichi Inohara
Rankless by CCL
2026